Osman Syed caused BioDX Labs to submit more than $79 million in fraudulent claims to Medicare and Texas Medicaid for respiratory pathogen panel tests that were not provided and were medically unnecessary, the Justice Department said in a Nov. 20 news release.
According to the release, Mr. Syed used the personal identifying information of a physician, without the physician’s knowledge or consent, to submit the claims for the RPP tests. The physician had no prior relationship, nor was treating the beneficiaries and recipients.
To conceal the tests, Mr. Osman falsely represented that BioDX used reference laboratories to perform its testing.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.